Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 464
IsoRay scores additional financing
By
AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical has closed on $16.5 million in equity financing.
March 22, 2007
AnazaoHealth provides teddy bears for pediatric I-123 MIBG patients
By
AuntMinnie.com staff writers
The nuclear medicine division of AnazaoHealth has launched a program to provide a teddy bear to each child patient receiving an iodine-123 metaiodobenzylguanidine (I-123 MIBG) dose.
March 22, 2007
Avid releases results for PET Alzheimer's agent
By
AuntMinnie.com staff writers
Molecular imaging developer Avid Radiopharmaceuticals of Philadelphia has released results of the company's first clinical study of a new radiopharmaceutical designed to provide PET imaging of Alzheimer's disease.
March 22, 2007
SPECT/CT offers on-target diagnosis in noncancerous bone disease
By
Shalmali Pal
There's no shortage of research on SPECT/CT in oncologic imaging and the fact that bone scintingraphy has its limitations in this setting. But what about patients who are referred for nononcologic imaging? Is bone scintigraphy any more useful? No, according to nuclear medicine specialists from Israel, who advocated using SPECT plus multislice low-dose CT (MslCT) instead.
March 22, 2007
Siemens, M. D. Anderson boost collaboration
By
AuntMinnie.com staff writers
Siemens Medical Solutions said that it has expanded its molecular imaging research collaboration with the University of Texas M. D. Anderson Cancer Center with the establishment of a preclinical research center dedicated to the development of new, targeted biomarkers.
March 21, 2007
MDS Nordion to expand Belgian FDG facility
By
AuntMinnie.com staff writers
Radioisotope developer MDS Nordion of Kanata, Ontario, is investing $5.8 million (U.S.) to expand its production facility in Fleurus, Belgium, to meet the demand for the imaging agent fluorine-18 fluorodeoxyglucose (F-18 FDG).
March 21, 2007
GE bullish on BGO PET crystal technology
By
AuntMinnie.com staff writers
Despite a slowdown in equipment purchasing caused by the Deficit Reduction Act (DRA) of 2005, GE Healthcare will continue to pursue long-term sourcing agreements with its bismuth germinate (BGO) crystal suppliers for its PET and PET/CT systems, the Discovery LS, Discovery ST, and Discovery STE.
March 20, 2007
Tyco Healthcare names Wright as pharma/imaging president
Tyco Healthcare, a St. Louis-based subsidiary of industrial conglomerate Tyco International of Pembroke, Bermuda, has appointed Timothy Wright as president of its pharmaceutical and imaging solutions business units.
March 19, 2007
IBA increases sales and profit in 2006
By
AuntMinnie.com staff writers
Buoyed by a 44% hike in European sales for its radioisotopes, nuclear medicine products firm Ion Beam Applications (IBA) posted sales growth and greater profits in 2006.
March 14, 2007
Eckert & Ziegler ends deal with RadQual
By
AuntMinnie.com staff writers
Radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products said that RadQual has informed the company that it has now developed its own process to manufacture gamma camera flood sources and that it is no longer using Eckert & Ziegler technology.
March 14, 2007
Molecular markers: Putting too fine a point on DCIS?
By
Shalmali Pal
KEY LARGO, FL - The great promise of genetic testing and molecular markers may be all the rage right now, but that doesn't mean good old-fashioned imaging and pathology will fall by the wayside. At least that's the opinion of an expert panel at the Breast Course 2007 this week that discussed the role genetic information will play for assessing ductal carcinoma in situ (DCIS).
March 14, 2007
SoftScan clinical trial moves ahead
By
AuntMinnie.com staff writers
KEY LARGO, FL - Optical molecular imaging developer ART Advanced Research Technologies has enrolled 320 patients in phase III of a 950-person clinical trial for SoftScan, currently under way at several Canadian institutions.
March 11, 2007
Previous Page
Page 464 of 611
Next Page